Withdrawal from controlled carbamazepine therapy followed by further carbamazepine treatment in patients with dementia

Journal of Clinical Psychiatry

Volumn 60, Issue 10, 1999, Pages 684-689

  Tariot, Pierre N ^a,c   Jakimovich, Laura J ^a   Erb, Rosemary ^a   Cox, Christopher ^b   Lanning, Benjamin ^a   Irvine, Carrie ^b   Podgorski, Carol Ann ^a  

^a Department of Psychiatry ^*  (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c Monroe Community Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE;

AGED; AGITATION; ARTICLE; BEHAVIOR; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEMENTIA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MUSCULOSKELETAL DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RASH;

EID: 0032742214     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v60n1007     Document Type: Article

References (17)

1. Tariot P, Mack JL, Patterson MB, et al., and the CERAD Behavioral Pathology Committee. The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 1995;152:1349-1357
2. Cohen-Mansfield J. Agitated behaviors in the elderly, II: preliminary results in the cognitively deteriorated. J Am Geriatr Soc 1986;34: 722-727
3. Finkel SI, Costa e Silva J, Cohen G, et al. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996;8(suppl 3):497-500
4. Cohen-Mansfield I, Billig N. Agitated behaviors in the elderly, I: a conceptual review. J Am Geriatr Soc 1986;34:711-721
5. Tariot PN. Treatment strategies for agitation and psychosis in dementia. J Clin Psychiatry 1996;57(suppl 14):21-29
6. Leibovici A, Tariot PN. Carbamazepine treatment of agitation associated with dementia. J Geriatr Psychiatry Neurol 1988;1:110-112
7. Tariot PN, Erb R, Leibovici A, et al. Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. J Am Geriatr Soc 1994;42:1160-1166
8. Tariot PN, Frederiksen K, Erb R, et al. Lack of carbamazepine toxicity in frail nursing home patients: a controlled study. J Am Geriatr Soc 1995;43:1026-1029
9. Tariot PN, Erb R, Podgorski CA, et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998;155:54-61
10. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944
11. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
12. Overall JE, Gorham DR. Introduction: the Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 1988;24:101-104
13. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976;217-222
14. Yudofsky SC, Silver JM, Jackson W, et al. The Overt Aggression Scale for objective rating of verbal and physical aggression. Am J Psychiatry 1986;143:35-39
15. Lawton MP, Brody E. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9: 179-186
16. Overall JE, Beller SA. The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research, I: factor structure on an inpatient unit. J Gerontol 1984;39:187-193
17. Porsteinsson AP, Tariot PN, Erb R, et al. An open trial of valproate for agitation in geriatric neuropsychiatric disorders. Am J Geriatr Psychiatry 1997;5:344-351